These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25000468)

  • 1. Diffuse hemorrhagic colitis in a patient with dyskeratosis congenita after nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Ehlert K; Rossig C; Groll AH; Beyna T; Froehlich B; Juergens H
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e41-4. PubMed ID: 25000468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita.
    Elmahadi S; Muramatsu H; Kojima S
    Curr Opin Hematol; 2016 Nov; 23(6):501-507. PubMed ID: 27607446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.
    Dietz AC; Orchard PJ; Baker KS; Giller RH; Savage SA; Alter BP; Tolar J
    Bone Marrow Transplant; 2011 Jan; 46(1):98-104. PubMed ID: 20383216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita: report of a case.
    Comoli P; Basso S; Huanga GC
    Int J Hematol; 2005 Jul; 82(1):35-7. PubMed ID: 16105756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransplant lymphoproliferative disorder complicating hematopoietic stem cell transplantation in a patient with dyskeratosis congenita.
    Bohn OL; Whitten J; Spitzer B; Kobos R; Prockop S; Boulad F; Arcila M; Wang L; Teruya-Feldstein J
    Int J Surg Pathol; 2013 Oct; 21(5):520-5. PubMed ID: 23222806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Second Unrelated Donor Hematopoietic Stem Cell Transplant in a Patient With Dyskeratosis Congenital After First Graft Rejection.
    Giardino S; Faraci M; Lanino E; Morreale G; Terranova P; Palmisani E; Dufour C; Miano M
    Exp Clin Transplant; 2023 Apr; 21(4):368-374. PubMed ID: 28969530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita.
    Güngör T; Corbacioglu S; Storb R; Seger RA
    Bone Marrow Transplant; 2003 Mar; 31(5):407-10. PubMed ID: 12634734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dyskeratosis congenita: an update].
    Mialou V; Leblanc T; Peffault de Latour R; Dalle JH; Socié G
    Arch Pediatr; 2013 Mar; 20(3):299-306. PubMed ID: 23352883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita.
    Nishio N; Takahashi Y; Ohashi H; Doisaki S; Muramatsu H; Hama A; Shimada A; Yagasaki H; Kojima S
    Pediatr Transplant; 2011 Mar; 15(2):161-6. PubMed ID: 21176016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyskeratosis congenita.
    Savage SA; Alter BP
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):215-31. PubMed ID: 19327580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita.
    Fioredda F; Iacobelli S; Korthof ET; Knol C; van Biezen A; Bresters D; Veys P; Yoshimi A; Fagioli F; Mats B; Zecca M; Faraci M; Miano M; Arcuri L; Maschan M; O'Brien T; Diaz MA; Sevilla J; Smith O; Peffault de Latour R; de la Fuente J; Or R; Van Lint MT; Tolar J; Aljurf M; Fisher A; Skorobogatova EV; Diaz de Heredia C; Risitano A; Dalle JH; Sedláček P; Ghavamzadeh A; Dufour C
    Br J Haematol; 2018 Oct; 183(1):110-118. PubMed ID: 29984823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal Hemorrhagic Gastrointestinal Angioectasia after Bone Marrow Transplantation for Dyskeratosis Congenita.
    Imai J; Suzuki T; Yoshikawa M; Dekiden M; Nakae H; Nakahara F; Tsuda S; Mizukami H; Koike J; Igarashi M; Yabe H; Mine T
    Intern Med; 2016; 55(23):3441-3444. PubMed ID: 27904106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after Hematopoietic Stem Cell Transplant in Patients with Dyskeratosis Congenita: Systematic Review of the Literature.
    Barbaro P; Vedi A
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1152-1158. PubMed ID: 26968789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Transplant for Management of Hepatic Complications of Dyskeratosis Congenita: A Case Report.
    Alebrahim M; Akateh C; Arnold CA; Benissan-Messan D; Chavez JA; Singh N; Al-Adwan Y; El-Hinnawi A; Michaels A; Black SM
    Exp Clin Transplant; 2022 Jul; 20(7):702-705. PubMed ID: 33272154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyskeratosis congenita: A case report on a rare disease.
    Khaliq S; Hasan Kazmi SK
    J Pak Med Assoc; 2021 Mar; 71(3):1007-1010. PubMed ID: 34057965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic Hematopoietic Cell Transplantation for Dyskeratosis Congenita: A Report of 3 Cases.
    Tamura S; Imamura T; Urata T; Kobayashi M; Gen M; Tomii T; Do J; Osone S; Ishida H; Hosoi H; Kuroda H
    J Pediatr Hematol Oncol; 2017 Oct; 39(7):e394-e398. PubMed ID: 28538506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile Idiopathic Inflammatory Myopathy in a Patient With Dyskeratosis Congenita Due to C16orf57 Mutation.
    Kilic SS; Cekic S
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):e75-7. PubMed ID: 26535771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fludarabine, low-dose cyclophosphamide and rabbit antithymocyte globulin allowed stable engraftment after allogeneic peripheral blood stem cell transplantation for poly-transfused dyskeratosis congenita patient: case report.
    Coliţă A; Tanase A; Varady Z; Coliţă AD; Arion C
    Transplant Proc; 2013 Sep; 45(7):2849-53. PubMed ID: 24034063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita.
    Dror Y; Freedman MH; Leaker M; Verbeek J; Armstrong CA; Saunders FE; Doyle JJ
    Bone Marrow Transplant; 2003 May; 31(10):847-50. PubMed ID: 12748659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulin.
    Ayas M; Al-Musa A; Al-Jefri A; Al-Seraihi A; Al-Mahr M; Rifai S; El-Solh H
    Pediatr Blood Cancer; 2007 Jul; 49(1):103-4. PubMed ID: 16317729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.